Terms: = Ovarian cancer AND NSD1, FLJ44628, 64324, ENSG00000165671, Q96L73, FLJ22263, DKFZp666C163, ARA267, STO, SOTOS AND Treatment
4 results:
1. Risk factors for developing peritoneal metastases after curative surgery for colorectal cancer: A systematic review and meta-analysis.
Zhang Y; Qin X; Chen W; Liu D; Luo J; Wang H; Wang H
Colorectal Dis; 2021 Nov; 23(11):2846-2858. PubMed ID: 34411399
[TBL] [Abstract] [Full Text] [Related]
2. [A challenge for colorectal surgeons: pathogenesis, progression and management of the secondary tumors of the ovary].
Shi JY; Yang Y; Huang A; Xu JX; Cheng Y; Li YK; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jun; 24(6):550-556. PubMed ID: 34148321
[TBL] [Abstract] [Full Text] [Related]
3. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
[TBL] [Abstract] [Full Text] [Related]
4. Activated CAMKKβ-AMPK signaling promotes autophagy in a spheroid model of ovarian tumour metastasis.
Laski J; Singha B; Wang X; Valdés YR; Collins O; Shepherd TG
J Ovarian Res; 2020 May; 13(1):58. PubMed ID: 32393385
[TBL] [Abstract] [Full Text] [Related]
